Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid Rebate Cases To Focus On “Slam Dunks”; Industry Wants Guidance

Executive Summary

Guidance for pharmaceutical manufacturers regarding compliance with the Medicaid rebate statute will most likely be obtained through regulations rather than case law, a former Department of Justice lawyer said

You may also be interested in...



King Medicaid Rebate Data Sought By SEC; Subpoena Includes Altace Rebates

The Securities & Exchange Commission is asking King to provide information about its Medicaid rebate calculations as part of a broad subpoena disclosed by the company March 11

Schering Sets Aside $150 Mil. For Liabilities In Marketing Investigations

Schering-Plough is estimating its "minimum liability" in pending investigations of its marketing practices at the low end of recent settlements within the pharmaceutical industry

CMS Wants Bigger Medicaid Rebates, Elimination Of “Best Price”

The Bush Administration is proposing to eliminate the "best price" component of the Medicaid rebate system - and require a deeper mandatory discount

Related Content

UsernamePublicRestriction

Register

OM013202

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel